8.4-PNEUMOCYSTIS PNEUMONIA+PENICILLIOSIS+OTHER OPPORTUNISTIC MYCOSES Flashcards

(60 cards)

1
Q

What organism causes Pneumocystis pneumonia (PCP)?

A

Pneumocystis jiroveci (formerly P. carinii)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What type of patients does P. jiroveci primarily affect?

A

Immunocompromised patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How common is dissemination of P. jiroveci?

A

Rare

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Before the AIDS epidemic, what was the main population affected by P. jiroveci?

A

Malnourished infants and immunosuppressed patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Before effective prophylaxis, what was a major cause of death in AIDS patients?

A

Pneumocystis pneumonia (PCP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What organs can P. jiroveci affect apart from the lungs?

A

Spleen, lymph nodes, bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the major stages in the life cycle of P. jiroveci?

A

Trophozoite → Precyst → Cyst → Sporozoites → Trophozoites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the function of trophozoites in P. jiroveci?

A

Feeding stage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Is P. jiroveci an intracellular or extracellular pathogen?

A

Extracellular

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where does P. jiroveci grow in the lung?

A

Surfactant layer above alveolar epithelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the two morphologically distinct forms of P. jiroveci?

A

Thin-walled trophozoites and thick-walled cysts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the characteristics of the cysts?

A

Thick-walled, spherical to elliptical (4–6 µm), containing 4–8 nuclei

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What surface marker is found in P. jiroveci and can be detected in sera?

A

Surface glycoprotein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the ideal specimen for diagnosing Pneumocystis pneumonia?

A

Bronchoalveolar lavage (BAL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What other specimens can be used?

A

Lung biopsy tissue, induced sputum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What stains are appropriate for detecting P. jiroveci?

A

Giemsa, toluidine blue, methenamine silver, calcofluor white

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Can P. jiroveci be cultured?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Does P. jiroveci cause disease in immunocompetent individuals?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Has a natural reservoir for P. jiroveci been identified?

A

No

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is known about the mode of infection for P. jiroveci?

A

Unclear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

When are most individuals infected with P. jiroveci?

A

Early childhood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the global distribution of P. jiroveci?

A

Worldwide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What type of immunity plays a dominant role in resistance to disease?

A

Cell-mediated immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

At what CD4 count does Pneumocystis pneumonia usually appear in AIDS patients?

A

Below 400 cells/µL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
What are the two main treatment options for Pneumocystis pneumonia?
Trimethoprim-sulfamethoxazole or pentamidine isethionate
26
How can prophylaxis be achieved?
Daily trimethoprim-sulfamethoxazole or aerosolized pentamidine
27
What organism causes Penicilliosis?
Penicillium marneffei (Talaromyces marneffei)
28
What type of infection does P. marneffei cause?
Systemic infection in immunocompromised patients
29
How has P. marneffei emerged as a pathogen?
As an endemic, opportunistic pathogen
30
In which regions is P. marneffei endemic?
Southeast Asia, including China, Thailand, Vietnam, Indonesia, Hong Kong, Taiwan, Manipur (India)
31
Where is P. marneffei commonly isolated from?
Soil, especially soil associated with bamboo rats and their habitats
32
What is the colonial appearance of P. marneffei in mold form?
Green-yellow colony with diffusible reddish pigment
33
What is the microscopic appearance of P. marneffei in mold form?
Septate, branching hyphae, brushlike aerial conidiospores, phialides, and basipetal chains of conidia
34
What is the microscopic appearance of P. marneffei in tissue form?
Unicellular yeast-like cells (2 × 6 µm) dividing by fission
35
What are the major risk factors for Penicilliosis?
HIV/AIDS, tuberculosis, corticosteroid treatment, lymphoproliferative diseases
36
What are the clinical manifestations of Penicilliosis?
Fungemia, skin lesions, systemic involvement (especially reticuloendothelial system)
37
What are the signs and symptoms of Penicilliosis?
Cough, fever, fatigue, weight loss, lymphadenopathy, cutaneous/subcutaneous papules or rashes
38
What specimens are used for diagnosing Penicilliosis?
Skin, blood, or tissue biopsies
39
How is Penicilliosis diagnosed?
Microscopic observation of yeast-like cells and positive cultures
40
What is the treatment for Penicilliosis?
Amphotericin B (initial course), Itraconazole (follow-up therapy)
41
What are opportunistic mycoses?
Globally distributed fungal infections with high incidence, severity, and mortality
42
What innate host defenses protect against systemic candidiasis, invasive aspergillosis, and mucormycosis?
Neutrophils & monocytes
43
What types of patients are at high risk for opportunistic mycoses?
Those with hematologic dyscrasias, immunosuppressive or cytotoxic drug treatment
44
What fungal infections commonly affect HIV/AIDS patients?
Mucosal candidiasis (e.g., thrush, esophagitis)
45
Which fungal infections occur in AIDS patients with CD4 counts <100 cells/µL?
Cryptococcosis, Pneumocystis pneumonia, Aspergillosis, Penicilliosis, Endemic mycoses
46
Why is invasive aspergillosis or candidiasis difficult to diagnose?
Blood cultures are negative in aspergillosis, <50% positive in systemic candidiasis
47
What is the key to successful management of opportunistic mycoses?
Early diagnosis, rapid antifungal therapy, control of underlying disease
48
What diseases does Geotrichum candidum cause?
Pulmonary disease, wound infections, and oral thrush
49
What is the key microscopic feature of Geotrichum candidum?
Abundant arthroconidia due to fragmentation of hyphae
50
What disease is Fusarium commonly associated with?
Mycotic keratitis
51
What is the distinctive microscopic feature of Fusarium?
Banana- or canoe-shaped macroconidia clustered in mats (sporodochia)
52
What is unique about Fusarium macroconidia?
Only mycoses with banana-/canoe-shaped macroconidia
53
What are the colony colors of Fusarium?
Rose, mauve, purple, yellow
54
What are opportunistic mycoses?
Globally distributed fungal infections that cause high morbidity and mortality in immunocompromised patients
55
Which mycoses have the highest incidence, severity, and mortality?
Systemic opportunistic mycoses
56
What innate host defenses protect against systemic opportunistic mycoses?
Neutrophils & monocytes
57
What part of the immune system plays an additional role in defense?
Adaptive immune response, particularly cell-mediated immunity
58
What patients are at high risk for opportunistic mycoses?
Patients with hematologic dyscrasias (e.g., leukemia, anemia) and immunosuppressive or cytotoxic drug treatment
59
What fungal infection is common in most HIV/AIDS patients?
Mucosal candidiasis (thrush, esophagitis)
60
Patients with CD4 counts <100 cells/µL are at risk for what infections?
Cryptococcosis, Pneumocystis pneumonia, Aspergillosis, Penicilliosis, Endemic mycoses, Other opportunistic fungal infections